Tomasz Cichoń Selected Research

D-K6L9 peptide

8/2014

D-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomasz Cichoń Research Topics

Disease

27	Neoplasms (Cancer) 08/2021 - 09/2002
17	Melanoma (Melanoma, Malignant) 08/2021 - 09/2002
5	Hypoxia (Hypoxemia) 01/2021 - 10/2011
3	Necrosis 08/2021 - 04/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2002
1	Multiple Myeloma 01/2021
1	Vascular Tissue Neoplasms 06/2020
1	Peripheral Arterial Disease 11/2019
1	Nasopharyngeal Carcinoma 06/2010
1	Hemolysis 06/2010
1	Experimental Melanoma 01/2009
1	Cystic Fibrosis (Mucoviscidosis) 03/2005
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2005
1	Carcinoma (Carcinomatosis) 09/2002

Drug/Important Bio-Agent (IBA)

6	Interleukin-12 (IL 12)IBA 01/2021 - 06/2010
6	Peptides (Polypeptides)IBA 11/2016 - 01/2006
6	Proteins (Proteins, Gene)FDA Link 11/2012 - 01/2002
5	Pharmaceutical PreparationsIBA 06/2021 - 01/2009
3	vadimezanIBA 08/2021 - 01/2018
3	Oxygen (Dioxygen)IBA 01/2021 - 10/2011
3	Therapeutic UsesIBA 01/2021 - 06/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2009
3	DNA (Deoxyribonucleic Acid)IBA 06/2010 - 09/2002
2	VaccinesIBA 06/2020 - 12/2015
2	Digoxin (Digitek)FDA LinkGeneric 03/2020 - 01/2018
2	CytokinesIBA 04/2014 - 10/2012
2	ProdrugsIBA 01/2014 - 07/2009
2	hydrazine (hydrazine dihydrochloride)IBA 01/2014 - 07/2009
2	HMGB1 Protein (HMG1)IBA 11/2012 - 10/2012
2	Liposomes (Liposome)IBA 06/2010 - 01/2009
1	FlavonoidsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	daratumumabIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	DNA VaccinesIBA 01/2018
1	EndoglinIBA 01/2018
1	glutaminyl- arginyl- phenylalanyl- seryl- arginineIBA 11/2016
1	Antimicrobial PeptidesIBA 11/2016
1	sialorphinIBA 11/2016
1	PhosphatidylserinesIBA 08/2014
1	D-K6L9 peptideIBA 08/2014
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 08/2014
1	InterleukinsIBA 04/2014
1	Recombinant ProteinsIBA 04/2014
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2014
1	Melphalan (Alkeran)FDA LinkGeneric 01/2014
1	Tyrosine (L-Tyrosine)FDA Link 01/2014
1	vasostatinIBA 01/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012
1	Fibronectins (Fibronectin)IBA 10/2011
1	NM23 Nucleoside Diphosphate KinasesIBA 10/2011
1	CD146 AntigenIBA 10/2011
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2011
1	Microphthalmia-Associated Transcription FactorIBA 10/2011
1	Galectin 3 (LGALS3)IBA 10/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 06/2010
1	OligopeptidesIBA 06/2010
1	Antineoplastic Agents (Antineoplastics)IBA 07/2009
1	EnzymesIBA 07/2009
1	Carbidopa (Lodosyn)FDA LinkGeneric 07/2009
1	Levodopa (L Dopa)FDA LinkGeneric 07/2009
1	Monophenol Monooxygenase (Tyrosinase)IBA 07/2009
1	Protein Isoforms (Isoforms)IBA 01/2009
1	fosbretabulin (combretastatin A4)IBA 01/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2009
1	liposomal doxorubicin (Doxil)FDA Link 01/2009
1	Integrin alphaVbeta3IBA 01/2006
1	AlbuminsIBA 03/2005
1	Angiogenesis InhibitorsIBA 09/2002
1	EndostatinsIBA 09/2002

Therapy/Procedure

16	Therapeutics 06/2021 - 01/2006
4	Radiotherapy 08/2021 - 01/2018
3	Brachytherapy 08/2021 - 06/2020
1	Donor Selection 01/2021
1	Investigational Therapies (Experimental Therapy) 01/2021
1	Immunotherapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2018
1	Injections 06/2010
1	Electrodes (Electrode) 09/2002